LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Clinical trials for LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG explained in plain language.
Never miss a new study
Get alerted when new LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG trials appear
Sign up with your email to follow new studies for LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive cancer fighter enters first human trials
Disease control Recruiting nowThis early-stage study is testing a new radioactive drug called 225Ac-ABD147 for people with two aggressive types of lung cancer that have progressed after standard chemotherapy. Researchers will first determine safe doses and track where the drug goes in the body, then evaluate …
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Phase: PHASE1 • Sponsor: Abdera Therapeutics Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Radioactive 'Warhead' drug targets tough cancers in first human trial
Disease control Recruiting nowThis is an early-stage study to test the safety and find the right dose of a new radioactive drug called [225Ac]Ac-ETN029 for adults with advanced cancers that have a protein called DLL3. The trial will also test an imaging version of the drug to see where it goes in the body. Re…
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New combo attack on tough cancers: radiation meets targeted drug
Disease control Recruiting nowThis study is testing whether it is safe to combine a new targeted drug called tarlatamab with standard radiation therapy. It is for adults with advanced cancers that have a specific protein called DLL3, including certain lung cancers, melanoma, and others. The main goal is to se…
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Phase: PHASE1, PHASE2 • Sponsor: University of Arizona • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC